期刊文献+

Pericarditis following COVID-19 vaccination:Two case reports

下载PDF
导出
摘要 BACKGROUND Coronavirus disease 2019(COVID-19)is a highly contagious viral illness which conventionally manifests with primarily respiratory symptoms and less commonly with cardiac involvement in various forms,such as pericarditis.Myocarditis and pericarditis have been reported in a variety of live and attenuated vaccines,such as smallpox and influenza.As of October 2021,no cases of pericarditis associated with COVID-19 vaccination have been published.We present two healthy male patients who present post COVID-19 vaccination with pericarditis diagnoses.CASE SUMMARY A 21-year-old male with no significant past medical history presented with myalgia,chills,mild headache,and chest pain for two days.Patient received the Moderna COVID-19 vaccine the day prior to symptom onset.On presentation,electrocardiogram(ECG)revealed sinus rhythm with ST elevation,and troponin was elevated.Emergent cardiac catheterization was not significant for abnormalities.The primary diagnosis was acute pericarditis,and the patient was discharged on colchicine and indomethacin.Additionally,a 35-year-old male with no pertinent past medical history presented with fever,chills,weakness,nausea,vomiting,diarrhea,and retrosternal chest pain for three days.He received the Moderna COVID-19 vaccine four days prior to symptom onset.On presentation,troponin was elevated,and ECG revealed mild ST elevation.Left ventricular dysfunction with ejection fraction of 41%was reported on transthoracic echocardiogram.Patient was started on ibuprofen and colchicine for diagnosis of myopericarditis.CONCLUSION These case reports highlight a potential unintended consequence,pericarditis,associated with COVID-19 vaccination that may not warrant invasive cardiac intervention.
出处 《World Journal of Clinical Infectious Diseases》 2022年第1期33-40,共8页 世界临床传染病学杂志
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部